Hybrid Closed-Loop (HCL) Therapy for People with Type 1 Diabetes who are Pregnant - NHS England
8th October 2024
AIM:
The aim of this webinar is to outline the process and pathways for providing HCL therapy in pregnancy
FOCUS:
The NHS 5-year implementation strategy for HCL technologies
Maximising the benefits of HCL for women with Type 1 diabetes who are pregnant
Practical examples of how maternity services have put HCL onboarding protocols in place
Key considerations for ICS leads
SPEAKERS:
Eleanor M. Scott (Chair) - Professor of Medicine (Diabetes and Maternal Health), University of Leeds & Leeds Teaching Hospitals Trust
Partha Kar - Type 1 Diabetes & Technology Lead. Consultant Diabetes, Portsmouth Hospitals University NHS Trust
Helen R. Murphy - Professor of Medicine, University of East Anglia (UEA), Norwich UK, Honorary Consultant Physician, Norfolk & Norwich University NHS Hospital Trust, Chair National Pregnancy in Diabetes (NPID) audit
Nina Willer - Diabetes Specialist Midwife, Norfolk & Norwich University NHS Hospital Trust
Emma Wilmot – Associate Professor, University of Nottingham School of Medicine, Honorary Consultant Diabetologist,University Hospitals of Derby and Burton. Founder, Diabetes Technology Network UK
Karen Kennedy - Assistant Director, National Diabetes Programme, NHS England
WEBINAR RESOURCES:
Battelino Et Al Clinical Targets For Continuous Glucose Monitoring Data Interpretation [1.39 MB]
Feig Et Al CGM In Pregnant Women With T1D CONCEPTT [1.18 MB]
HCL Pregnancy Webinar Slide Deck Oct 2024 [4.90 MB]
Lawton Et Al Listening To Women Experiences Of Using Closed Loop In T1D Pregnancy [269.68 KB]
Murphy Et Al Modelling Potential Cost Savings From Use Of Real Time CGM In T1D Pregnancy [242.09 KB]
Scott Et Al CONCEPTT To Care The Science Of Implementation In Diabetes Care [125.43 KB]